ANATOMIC STAGE II BREAST CANCER AJCC V8
Clinical trials for ANATOMIC STAGE II BREAST CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new ANATOMIC STAGE II BREAST CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for ANATOMIC STAGE II BREAST CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial aims to cut chemo time and side effects for breast cancer patients
Disease control Recruiting nowThis large, phase 3 trial is comparing two chemotherapy approaches for early-stage triple-negative breast cancer. It aims to see if a shorter treatment that avoids a harsh drug called an anthracycline works as well as the standard, longer regimen. The study will enroll 2,400 part…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Vaccine joins fight against breast cancer in new trial
Disease control Recruiting nowThis study is testing whether adding an experimental vaccine called WOKVAC to standard pre-surgery treatment can help the immune system better fight HER2-positive breast cancer. The trial will enroll 25 adults with early-stage breast cancer to receive the vaccine along with their…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New study tests which hormone blocker works best for younger breast cancer patients
Disease control Recruiting nowThis study compares two different hormone-blocking treatments (leuprolide and goserelin) for premenopausal women with breast cancer. Both drugs work by reducing estrogen production, which can help slow or stop cancer growth. Researchers will measure how well each treatment lowers…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Personalized weight loss plans aim to boost survival for latina breast cancer survivors
Disease control Recruiting nowThis study is testing different remote weight loss programs designed specifically for Latina women who have survived early-stage breast cancer. Researchers want to see if personalized, community-focused support can help participants lose weight and improve their long-term health.…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Doctors test custom cancer vaccine to train immune system
Disease control Recruiting nowThis early-stage trial is testing a new, personalized vaccine for triple-negative breast cancer (TNBC). The vaccine is custom-made from a piece of a patient's own tumor and is designed to teach their immune system to recognize and attack the cancer. Researchers are studying the v…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Major trial aims to stop High-Risk breast cancer from coming back
Disease control Recruiting nowThis large, late-stage trial is testing if adding an immunotherapy drug called durvalumab to standard chemotherapy is better than chemotherapy alone for preventing cancer from returning. It is for adults with a specific high-risk type of breast cancer that is hormone-positive and…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Could skipping extra treatment keep cancer away just as well?
Disease control Recruiting nowThis large study is for people with early-stage triple-negative breast cancer who had no detectable cancer left after their initial chemo-immunotherapy and surgery. It aims to find out if simply watching closely (observation) works just as well at preventing the cancer from comin…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
5 days instead of weeks: new hope for faster breast cancer treatment
Disease control Recruiting nowThis study is testing a much shorter radiation schedule for people with early-stage breast cancer. Instead of treatments over several weeks, participants receive radiation to the whole breast and the surgical area at the same time, completed in just 5 daily sessions. The main goa…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Faster radiation for breast cancer: can timing cut side effects?
Disease control Recruiting nowThis study is testing whether giving a shorter, more intense course of radiation therapy *before* breast cancer surgery is as safe and effective as giving it *after* surgery. It aims to see if the pre-surgery timing can reduce side effects and treatment time for 120 patients with…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New hope for Tough-to-Treat breast cancer: trial tests Hormone-Blocking drug
Disease control Recruiting nowThis study is testing if adding a hormone-blocking drug called darolutamide to standard chemotherapy and immunotherapy before surgery works better for a specific type of early-stage, triple-negative breast cancer. About 51 patients with this cancer type will be randomly assigned …
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: Vandana Abramson • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Major trial aims to halve treatment time for breast cancer patients
Disease control Recruiting nowThis large, phase 3 trial is testing if a shorter, 6-month course of targeted antibody therapy works as well as the standard 12-month course for patients with early-stage HER2-positive breast cancer. It is for patients who had no detectable cancer left after their initial chemoth…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Gentler chemo trial aims to spare older women harsh side effects
Disease control Recruiting nowThis study is testing whether a lower dose of a common chemotherapy combination (docetaxel and cyclophosphamide) works as well as the standard dose for women aged 65 and older with early-stage breast cancer. The main goal is to see if the reduced dose is easier to tolerate, cause…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC
-
Mayo clinic tests 'Twinkling' marker to improve breast cancer node detection
Diagnosis Recruiting nowThis early-stage study is testing a new type of biopsy marker designed to be easier for surgeons to see on ultrasound scans during breast cancer operations. The marker is placed in a cancerous lymph node before treatment and is meant to help guide surgeons to the correct node for…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 02, 2026 15:21 UTC
-
Common diabetes drug may shield breast cancer survivors from new health threat
Prevention Recruiting nowThis study is testing whether adding the diabetes medication metformin to standard healthy lifestyle advice can better prevent or reverse insulin resistance in women who have finished chemotherapy for early-stage breast cancer. Researchers want to see if metformin helps normalize…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE3 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Mar 25, 2026 14:09 UTC
-
Can a 'Brain Food' diet fight chemotherapy fog?
Symptom relief Recruiting nowThis study is testing whether following a specific healthy eating plan called the MIND diet can help reduce thinking and memory problems (often called 'chemobrain'), fatigue, and other symptoms in women undergoing chemotherapy for triple-negative breast cancer. Researchers will c…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC
-
New hope for hair loss in breast cancer patients
Symptom relief Recruiting nowThis early study is testing whether a pill or a foam version of the hair growth drug minoxidil works better to treat hair loss caused by hormone therapy in breast cancer patients. It will involve about 50 women with stage I-IV breast cancer who are experiencing this side effect. …
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
Beauty boost for breast cancer survivors: study tests if skincare eases medication side effects
Symptom relief Recruiting nowThis study aims to see if skincare consultations can improve skin appearance and quality of life for breast cancer survivors who are starting aromatase inhibitor therapy. Researchers will enroll 25 postmenopausal women with early-stage breast cancer to track skin changes using sp…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 23, 2026 15:19 UTC
-
Can a 10-Week program ease the burden for breast cancer patients?
Symptom relief Recruiting nowThis study is testing whether a 10-week stress reduction and support program is practical and helpful for patients with triple-negative breast cancer. The program teaches relaxation, coping skills, and problem-solving, while also connecting participants with social workers to hel…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:17 UTC
-
New program aims to help older breast cancer survivors reclaim their health
Symptom relief Recruiting nowThis study tests a specialized geriatric care program designed to help older adults who have finished curative treatment for early-stage breast cancer. The program involves comprehensive health assessments, personalized follow-up visits, and activity tracking to address physical,…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC
-
Can ancient yoga and modern education ease Survivors' struggle?
Symptom relief Recruiting nowThis study is testing whether two different wellness programs are practical and acceptable for breast cancer survivors who have finished their main treatment but still have a low quality of life. About 108 survivors will try either a multi-part program with yoga, nutrition advice…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Mar 17, 2026 13:09 UTC
-
Needles vs. pressure: new hope for black women battling breast cancer drug pain
Symptom relief Recruiting nowThis study is testing whether acupuncture or virtual acupressure can prevent severe joint pain caused by a common breast cancer medication. It focuses on Non-Hispanic Black postmenopausal women with early-stage breast cancer, as they are more likely to experience this side effect…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Mar 11, 2026 14:53 UTC
-
Tracking friendships and fitness after cancer: how relationships shape recovery
Knowledge-focused Recruiting nowThis study aims to understand how personal relationships and physical activity affect the well-being of young adults who have survived cancer. Researchers will follow 250 young adult survivors for one year, having them complete surveys and wear activity trackers. The goal is to l…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
New tool aims to guide women through tough breast cancer surgery decisions
Knowledge-focused Recruiting nowThis study is testing a new online tool designed to help women with early-stage breast cancer make informed decisions about surgery. The tool provides clear information about the risks of cancer in the other breast and the potential benefits of removing it preventively. Patients …
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Scientists track Body's hidden battle against breast cancer during treatment
Knowledge-focused Recruiting nowThis study aims to understand how the immune system reacts during standard treatments for HER2-positive breast cancer. Researchers will collect blood and tissue samples from 230 patients with stage I-IV breast cancer who are receiving or have received anti-HER2 drugs like trastuz…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC
-
Scientists gather clues from survivors to unlock breast Cancer's Long-Term secrets
Knowledge-focused Recruiting nowThis study is creating a large collection of blood samples and health information from people who have survived early-stage breast cancer. The goal is to build a resource for future scientists to study how factors like genetics, lifestyle, and environment affect long-term health …
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:03 UTC
-
Gene test could predict which breast cancers resist common drug
Knowledge-focused Recruiting nowThis study aims to understand if a specific gene mutation (HSD3B1) makes the breast cancer drug letrozole less effective. Postmenopausal women with early-stage, hormone-sensitive breast cancer will take letrozole for a few weeks before their standard surgery. Researchers will com…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Phase: PHASE4 • Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
Scientists track sleep patterns in breast cancer patients to uncover hidden health links
Knowledge-focused Recruiting nowThis study aims to understand how breast cancer treatment affects sleep patterns and quality. Researchers will follow 100 patients with early-stage breast cancer, having them wear sleep trackers and complete surveys from treatment through recovery. The goal is to identify factors…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC
-
Scientists probe Gut's role in Chemo's harsh side effects
Knowledge-focused Recruiting nowThis study aims to understand if changes in a person's gut bacteria are connected to the fatigue and nausea often experienced during chemotherapy for early-stage breast cancer. Researchers will collect stool and blood samples from about 70 women before and after their chemotherap…
Matched conditions: ANATOMIC STAGE II BREAST CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC